de la Torre, P.; Paris, J.L.; Fernández-de la Torre, M.; Vallet-RegÃ, M.; Flores, A.I.
Endostatin Genetically Engineered Placental Mesenchymal Stromal Cells Carrying Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Combined Chemo- and Antiangiogenic Therapy. Pharmaceutics 2021, 13, 244.
https://doi.org/10.3390/pharmaceutics13020244
AMA Style
de la Torre P, Paris JL, Fernández-de la Torre M, Vallet-Regà M, Flores AI.
Endostatin Genetically Engineered Placental Mesenchymal Stromal Cells Carrying Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Combined Chemo- and Antiangiogenic Therapy. Pharmaceutics. 2021; 13(2):244.
https://doi.org/10.3390/pharmaceutics13020244
Chicago/Turabian Style
de la Torre, Paz, Juan L. Paris, Miguel Fernández-de la Torre, MarÃa Vallet-RegÃ, and Ana I. Flores.
2021. "Endostatin Genetically Engineered Placental Mesenchymal Stromal Cells Carrying Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Combined Chemo- and Antiangiogenic Therapy" Pharmaceutics 13, no. 2: 244.
https://doi.org/10.3390/pharmaceutics13020244
APA Style
de la Torre, P., Paris, J. L., Fernández-de la Torre, M., Vallet-RegÃ, M., & Flores, A. I.
(2021). Endostatin Genetically Engineered Placental Mesenchymal Stromal Cells Carrying Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Combined Chemo- and Antiangiogenic Therapy. Pharmaceutics, 13(2), 244.
https://doi.org/10.3390/pharmaceutics13020244